- Home
- ATYR vs ALLT Comparison
ATYR vs ALLT Comparison
Compare ATYR & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- ALLT
- Stock Information
- Founded
- ATYR 2005
- ALLT 1996
- Country
- ATYR United States
- ALLT Israel
- Employees
- ATYR N/A
- ALLT N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- ALLT Telecommunications Equipment
- Sector
- ATYR Health Care
- ALLT Telecommunications
- Exchange
- ATYR Nasdaq
- ALLT Nasdaq
- Market Cap
- ATYR 126.3M
- ALLT 117.3M
- IPO Year
- ATYR 2015
- ALLT 2006
- Fundamental
- Price
- ATYR $1.87
- ALLT $2.95
- Analyst Decision
- ATYR Strong Buy
- ALLT Strong Buy
- Analyst Count
- ATYR 4
- ALLT 2
- Target Price
- ATYR $19.25
- ALLT $7.75
- AVG Volume (30 Days)
- ATYR 454.0K
- ALLT 65.1K
- Earning Date
- ATYR 11-07-2024
- ALLT 11-14-2024
- Dividend Yield
- ATYR N/A
- ALLT N/A
- EPS Growth
- ATYR N/A
- ALLT N/A
- EPS
- ATYR N/A
- ALLT N/A
- Revenue
- ATYR $588,000.00
- ALLT $91,031,000.00
- Revenue This Year
- ATYR N/A
- ALLT N/A
- Revenue Next Year
- ATYR $2,057.88
- ALLT $10.35
- P/E Ratio
- ATYR N/A
- ALLT N/A
- Revenue Growth
- ATYR N/A
- ALLT N/A
- 52 Week Low
- ATYR $1.08
- ALLT $1.19
- 52 Week High
- ATYR $2.50
- ALLT $3.62
- Technical
- Relative Strength Index (RSI)
- ATYR 55.26
- ALLT 43.78
- Support Level
- ATYR $1.67
- ALLT $2.81
- Resistance Level
- ATYR $1.81
- ALLT $3.07
- Average True Range (ATR)
- ATYR 0.08
- ALLT 0.12
- MACD
- ATYR 0.00
- ALLT -0.01
- Stochastic Oscillator
- ATYR 68.97
- ALLT 34.15
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. It has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.